• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Performance characteristics of a novel immunoassay based on hybrid Ty virus-like particles (Ty-VLPs): rapid differentiation between HIV-1 and HIV-2 infection.

作者信息

Gilmour J E, Read S J, Eglin R, Ryan C, Burns N R, Graff N, Stenner N, Kingsman S M, Kingsman A J, Adams S E

机构信息

British Bio-technology Ltd, Cowley, Oxford, UK.

出版信息

AIDS. 1990 Oct;4(10):967-73. doi: 10.1097/00002030-199010000-00004.

DOI:10.1097/00002030-199010000-00004
PMID:2124493
Abstract

Recombinant antigens containing all or parts of the HIV-1 proteins p24, Nef and gp41 and HIV-2 gp36 have been purified and used to develop a rapid immunoassay to detect and differentiate between HIV-1 and HIV-2 antibodies in a single test. The antigens were produced as particulate fusion proteins by exploiting the ability of a protein encoded by the yeast retrotransposon Ty to assemble into virus-like particles (Ty-VLPs). Hybrid HIV: Ty-VLPs carrying each of the antigens were applied to nitrocellulose strips at specified locations in a slot-blot format and then used to detect antibodies present in human serum and plasma samples of diverse geographical origin. Previously confirmed HIV-1- and HIV-2-positive samples were readily and reliably identified. The assay was used to identify a case of HIV-2 infection in an African woman who had been resident in the Oxford region for the last 3 years and to analyse the prevalence of anti-HIV antibodies in a longitudinal study of seroconverting patients. We also demonstrate that the assay works efficiently with whole blood.

摘要

相似文献

1
Performance characteristics of a novel immunoassay based on hybrid Ty virus-like particles (Ty-VLPs): rapid differentiation between HIV-1 and HIV-2 infection.
AIDS. 1990 Oct;4(10):967-73. doi: 10.1097/00002030-199010000-00004.
2
A novel method for the purification of HIV-1 p24 protein from hybrid Ty virus-like particles (Ty-VLPs).一种从杂交Ty病毒样颗粒(Ty-VLPs)中纯化HIV-1 p24蛋白的新方法。
AIDS. 1989 Nov;3(11):717-23. doi: 10.1097/00002030-198911000-00005.
3
Detection and differentiation of HIV-1 group O sera from HIV-1 group M and HIV-2 using recombinant antigens and peptides.使用重组抗原和肽检测及区分HIV-1 O组血清与HIV-1 M组和HIV-2。
J Virol Methods. 1998 May;72(1):43-9. doi: 10.1016/s0166-0934(98)00017-2.
4
Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.使用重组p24、gp41、gp120和gp36抗原评估一种用于确认1型和2型人类免疫缺陷病毒感染的新型斑点印迹检测法。
Saudi Med J. 2006 Jan;27(1):31-6.
5
The use of a chimera HIV-1/HIV-2 envelope protein for immunodiagnosis of HIV infection: its expression and purification in E. coli by use of a translation initiation site within HIV-1 env gene.嵌合HIV-1/HIV-2包膜蛋白用于HIV感染免疫诊断的研究:利用HIV-1 env基因内的翻译起始位点在大肠杆菌中进行表达和纯化。
Biochem Mol Biol Int. 1998 Oct;46(3):607-17. doi: 10.1080/15216549800204132.
6
Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 ag detection: a new generation vironostika HIV Uni-Form II.通过纳入HIV p24抗原检测,直接抗HIV-1/-2检测在血清转化中的敏感性得到显著增强:新一代Vironostika HIV Uni-Form II。
J Virol Methods. 1998 Dec;76(1-2):59-71. doi: 10.1016/s0166-0934(98)00126-8.
7
Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.使用重组抗原免疫印迹法对人类免疫缺陷病毒1型抗体进行可靠的确认和定量分析。
Transfusion. 1991 Feb;31(2):129-37. doi: 10.1046/j.1537-2995.1991.31291142943.x.
8
Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2.用于同时确认抗HIV-1和HIV-2抗体的线性免疫测定法的评估。
Eur J Clin Microbiol Infect Dis. 1991 Nov;10(11):939-46. doi: 10.1007/BF02005448.
9
Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.针对HIV-1的人源单克隆抗体:与gag和env产物的交叉反应
Clin Exp Immunol. 1989 Dec;78(3):323-8.
10
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.利用嵌合gag-env病毒样颗粒开发艾滋病毒/艾滋病疫苗。
Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047.